2024 annual financial data
Aktis Oncology 2024 Operating margin
Direct answer
Operating margin was -3,500.34%.
Operating income was -52,050,000 USD and net income was -43,980,000 USD.
Operating cash flow was 14,762,000 USD.
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,487,000 USD
- Operating income
- -52,050,000 USD
- Net income
- -43,980,000 USD
- Operating cash flow
- 14,762,000 USD